8 result(s) for Adolescent and Young Adult (AYA)
| PI Name | Protocol # | Title |
|---|---|---|
| Christopher Ryan | IRB00009464 | A Phase II Study of Sorafenib with Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas |
| Lara Davis | IRB00010529 | SARC024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing–like sarcomas |
| Sancy Leachman | IRB00010561 | War on Melanoma: Enlisting a cohort of melanoma survivors and their families |
| Brandon Hayes-Lattin | IRB00011894 | Protocol CCTL019B2206: A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial |
| Brandon Hayes-Lattin | IRB00011960 | Long Term Follow-Up of Patients Exposed to Lentiviral- Based CD19 directed CART Cell Therapy |
| Lara Davis | IRB00012039 | Sarcoma Survivorship Registry |
| Christopher Ryan | STUDY00015989 | A PHASE 2-3, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF SELINEXOR (KPT-330) VERSUS PLACEBO IN PATIENTS WITH ADVANCED UNRESECTABLE DEDIFFERENTIATED LIPOSARCOMA (DDLS) |
| Lara Davis | STUDY00016070 | A Phase 1B Study of Ribociclib in Combination with Doxorubicin in Advanced Soft Tissue Sarcomas |
You may also qualify for Phase 1 Program trials.